Works matching IS 19466234 AND DT 2017 AND VI 9 AND IP 375

Results: 6

Blunting CHIKV infection by keeping T cells in check.
Published in:
Science Translational Medicine, 2017, v. 9, n. 375, p. 1, doi. 10.1126/scitranslmed.aam6567
By:
- Gasque, Philippe;
- Jaffar-Bandjee, Marie Christine
Publication type:
Article
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.
Published in:
Science Translational Medicine, 2017, v. 9, n. 375, p. 1, doi. 10.1126/scitranslmed.aal2463
By:
- Sulkowski, Parker L.;
- Corso, Christopher D.;
- Robinson, Nathaniel D.;
- Scanlon, Susan E.;
- Purshouse, Karin R.;
- Bai, Hanwen;
- Yanfeng Liu;
- Sundaram, Ranjini K.;
- Hegan, Denise C.;
- Fons, Nathan R.;
- Breuer, Gregory A.;
- Yuanbin Song;
- Mishra-Gorur, Ketu;
- De Feyter, Henk M.;
- de Graaf, Robin A.;
- Surovtseva, Yulia V.;
- Kachman, Maureen;
- Halene, Stephanie;
- Günel, Murat;
- Glazer, Peter M.
Publication type:
Article
Fingolimod treatment abrogates chikungunya virus–induced arthralgia.
Published in:
Science Translational Medicine, 2017, v. 9, n. 375, p. 1, doi. 10.1126/scitranslmed.aal1333
By:
- Teck-Hui Teo;
- Yi-Hao Chan;
- Lee, Wendy W. L.;
- Fok-Moon Lum;
- Amrun, Siti Naqiah;
- Zhisheng Her;
- Rajarethinam, Ravisankar;
- Merits, Andres;
- Rötzschke, Olaf;
- Rénia, Laurent;
- Ng, Lisa F. P.
Publication type:
Article
Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.
Published in:
Science Translational Medicine, 2017, v. 9, n. 375, p. 1, doi. 10.1126/scitranslmed.aah6510
By:
- Bagó, Juli R.;
- Okolie, Onyi;
- Dumitru, Raluca;
- Ewend, Matthew G.;
- Parker, Joel S.;
- Werff, Ryan Vander;
- Underhill, T. Michael;
- Schmid, Ralf S.;
- Miller, C. Ryan;
- Hingtgen, Shawn D.
Publication type:
Article
Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension.
Published in:
Science Translational Medicine, 2017, v. 9, n. 375, p. 1, doi. 10.1126/scitranslmed.aah4923
By:
- Kossmann, Sabine;
- Lagrange, Jeremy;
- Jäckel, Sven;
- Jurk, Kerstin;
- Ehlken, Moritz;
- Schönfelder, Tanja;
- Weihert, Yvonne;
- Knorr, Maike;
- Brandt, Moritz;
- Ning Xia;
- Huige Li;
- Daiber, Andreas;
- Oelze, Matthias;
- Reinhardt, Christoph;
- Lackner, Karl;
- Gruber, Andras;
- Monia, Brett;
- Karbach, Susanne H.;
- Walter, Ulrich;
- Ruggeri, Zaverio M.
Publication type:
Article
Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis.
Published in:
Science Translational Medicine, 2017, v. 9, n. 375, p. 1, doi. 10.1126/scitranslmed.aah3438
By:
- Miner, Jonathan J.;
- Cook, Lindsey E.;
- Hong, Jun P.;
- Smith, Amber M.;
- Richner, Justin M.;
- Shimak, Raeann M.;
- Young, Alissa R.;
- Monte, Kristen;
- Poddar, Subhajit;
- Crowe Jr., James E.;
- Lenschow, Deborah J.;
- Diamond, Michael S.
Publication type:
Article

Works matching IS 19466234 AND DT 2017 AND VI 9 AND IP 375

Blunting CHIKV infection by keeping T cells in check.

2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.

Fingolimod treatment abrogates chikungunya virus–induced arthralgia.

Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.

Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension.

Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis.